Related Experiment Video
Updated: Jun 21, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Activation of Leukopoiesis in Rat Blood with Trimecaine-Based Ionic Compounds
Lyailya Baktybayeva1, Valentina Yu2,3, Alexey Zazybin3,4
1Biology and Biotechnology Department, Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan.
Abstract:
A study of myelostimulating activity of ionic compounds-trimecaine alkyl iodide derivatives under the cipher BIV (BIV-117, BIV-118, and BIV-119) was conducted on a model of doxorubicin pancytopenia in white laboratory rats. It was established that the compounds BIV-117 and BIV-119 had a pronounced leukopoiesis-stimulating activity, exceeding the activity of the methyluracil as a comparison drug. Compounds BIV-117 and BIV-119 had erythropoiesis- and thrombocytopoiesis-stimulating activity at the level of methyluracil.

